img

Global Therapeutic Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Therapeutic Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Therapeutic Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Therapeutic Vaccines market is projected to reach US$ 117470 million in 2034, increasing from US$ 31040 million in 2022, with the CAGR of 20.6% during the period of 2024 to 2034. Demand from Oncotherapy and Hepatitis B are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Therapeutic Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Therapeutic Vaccines key manufacturers include Northeast Biotherapeutics, Agenus, Vaccinogen Inc, CIMAB S.A, Dendreon, Corixa and AVAX Technologies, etc. Northeast Biotherapeutics, Agenus, Vaccinogen Inc are top 3 players and held % sales share in total in 2022.
Therapeutic Vaccines can be divided into Peptide Therapeutic Vaccine, Cell Therapeutic Vaccine and Nucleic Acid Therapeutic Vaccine,, etc. Peptide Therapeutic Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Therapeutic Vaccines is widely used in various fields, such as Oncotherapy, Hepatitis B, Tuberculosis and Herpes Simplex Virus, etc. Oncotherapy provides greatest supports to the Therapeutic Vaccines industry development. In 2022, global % sales of Therapeutic Vaccines went into Oncotherapy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Therapeutic Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Northeast Biotherapeutics
Agenus
Vaccinogen Inc
CIMAB S.A
Dendreon
Corixa
AVAX Technologies
Segment by Type
Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Nucleic Acid Therapeutic Vaccine

Segment by Application


Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Therapeutic Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Therapeutic Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Therapeutic Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Therapeutic Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Therapeutic Vaccines introduction, etc. Therapeutic Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Therapeutic Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Therapeutic Vaccines Market Overview
1.1 Therapeutic Vaccines Product Overview
1.2 Therapeutic Vaccines Market Segment by Type
1.2.1 Peptide Therapeutic Vaccine
1.2.2 Cell Therapeutic Vaccine
1.2.3 Nucleic Acid Therapeutic Vaccine
1.3 Global Therapeutic Vaccines Market Size by Type
1.3.1 Global Therapeutic Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Therapeutic Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Therapeutic Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Therapeutic Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Therapeutic Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Therapeutic Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Therapeutic Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Therapeutic Vaccines Sales Breakdown by Type (2018-2024)
2 Global Therapeutic Vaccines Market Competition by Company
2.1 Global Top Players by Therapeutic Vaccines Sales (2018-2024)
2.2 Global Top Players by Therapeutic Vaccines Revenue (2018-2024)
2.3 Global Top Players by Therapeutic Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Therapeutic Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Therapeutic Vaccines Market Competitive Situation and Trends
2.5.1 Therapeutic Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Therapeutic Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Therapeutic Vaccines Market
2.8 Key Manufacturers Therapeutic Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Therapeutic Vaccines Status and Outlook by Region
3.1 Global Therapeutic Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Therapeutic Vaccines Historic Market Size by Region
3.2.1 Global Therapeutic Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Therapeutic Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Therapeutic Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Therapeutic Vaccines Forecasted Market Size by Region
3.3.1 Global Therapeutic Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Therapeutic Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Therapeutic Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Therapeutic Vaccines by Application
4.1 Therapeutic Vaccines Market Segment by Application
4.1.1 Oncotherapy
4.1.2 Hepatitis B
4.1.3 Tuberculosis
4.1.4 Herpes Simplex Virus
4.1.5 Others
4.2 Global Therapeutic Vaccines Market Size by Application
4.2.1 Global Therapeutic Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Therapeutic Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Therapeutic Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Therapeutic Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Therapeutic Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Therapeutic Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Therapeutic Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Therapeutic Vaccines Sales Breakdown by Application (2018-2024)
5 North America Therapeutic Vaccines by Country
5.1 North America Therapeutic Vaccines Historic Market Size by Country
5.1.1 North America Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Therapeutic Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Therapeutic Vaccines Sales in Value by Country (2018-2024)
5.2 North America Therapeutic Vaccines Forecasted Market Size by Country
5.2.1 North America Therapeutic Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Therapeutic Vaccines Sales in Value by Country (2024-2034)
6 Europe Therapeutic Vaccines by Country
6.1 Europe Therapeutic Vaccines Historic Market Size by Country
6.1.1 Europe Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Therapeutic Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Therapeutic Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Therapeutic Vaccines Forecasted Market Size by Country
6.2.1 Europe Therapeutic Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Therapeutic Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Therapeutic Vaccines by Region
7.1 Asia-Pacific Therapeutic Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Therapeutic Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Therapeutic Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Therapeutic Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Therapeutic Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Therapeutic Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Therapeutic Vaccines Sales in Value by Region (2024-2034)
8 Latin America Therapeutic Vaccines by Country
8.1 Latin America Therapeutic Vaccines Historic Market Size by Country
8.1.1 Latin America Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Therapeutic Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Therapeutic Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Therapeutic Vaccines Forecasted Market Size by Country
8.2.1 Latin America Therapeutic Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Therapeutic Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Therapeutic Vaccines by Country
9.1 Middle East and Africa Therapeutic Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Therapeutic Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Therapeutic Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Therapeutic Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Therapeutic Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Therapeutic Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Therapeutic Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Northeast Biotherapeutics
10.1.1 Northeast Biotherapeutics Company Information
10.1.2 Northeast Biotherapeutics Introduction and Business Overview
10.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Northeast Biotherapeutics Therapeutic Vaccines Products Offered
10.1.5 Northeast Biotherapeutics Recent Development
10.2 Agenus
10.2.1 Agenus Company Information
10.2.2 Agenus Introduction and Business Overview
10.2.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Agenus Therapeutic Vaccines Products Offered
10.2.5 Agenus Recent Development
10.3 Vaccinogen Inc
10.3.1 Vaccinogen Inc Company Information
10.3.2 Vaccinogen Inc Introduction and Business Overview
10.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Vaccinogen Inc Therapeutic Vaccines Products Offered
10.3.5 Vaccinogen Inc Recent Development
10.4 CIMAB S.A
10.4.1 CIMAB S.A Company Information
10.4.2 CIMAB S.A Introduction and Business Overview
10.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 CIMAB S.A Therapeutic Vaccines Products Offered
10.4.5 CIMAB S.A Recent Development
10.5 Dendreon
10.5.1 Dendreon Company Information
10.5.2 Dendreon Introduction and Business Overview
10.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Dendreon Therapeutic Vaccines Products Offered
10.5.5 Dendreon Recent Development
10.6 Corixa
10.6.1 Corixa Company Information
10.6.2 Corixa Introduction and Business Overview
10.6.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Corixa Therapeutic Vaccines Products Offered
10.6.5 Corixa Recent Development
10.7 AVAX Technologies
10.7.1 AVAX Technologies Company Information
10.7.2 AVAX Technologies Introduction and Business Overview
10.7.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 AVAX Technologies Therapeutic Vaccines Products Offered
10.7.5 AVAX Technologies Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Therapeutic Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Therapeutic Vaccines Industrial Chain Analysis
11.4 Therapeutic Vaccines Market Dynamics
11.4.1 Therapeutic Vaccines Industry Trends
11.4.2 Therapeutic Vaccines Market Drivers
11.4.3 Therapeutic Vaccines Market Challenges
11.4.4 Therapeutic Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Therapeutic Vaccines Distributors
12.3 Therapeutic Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Peptide Therapeutic Vaccine
Table 2. Major Company of Cell Therapeutic Vaccine
Table 3. Major Company of Nucleic Acid Therapeutic Vaccine
Table 4. Global Therapeutic Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Therapeutic Vaccines Sales by Type (2018-2024) & (K Units)
Table 6. Global Therapeutic Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Therapeutic Vaccines Sales by Type (2018-2024) & (US& Million)
Table 8. Global Therapeutic Vaccines Market Share in Value by Type (2018-2024)
Table 9. Global Therapeutic Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 10. Global Therapeutic Vaccines Sales by Type (2024-2034) & (K Units)
Table 11. Global Therapeutic Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Therapeutic Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Therapeutic Vaccines Sales Market Share in Value by Type (2024-2034)
Table 14. Global Therapeutic Vaccines Price by Type (2024-2034) & (USD/Unit)
Table 15. North America Therapeutic Vaccines Sales by Type (2018-2024) & (K Units)
Table 16. North America Therapeutic Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Therapeutic Vaccines Sales (K Units) by Type (2018-2024)
Table 18. Europe Therapeutic Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Therapeutic Vaccines Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Therapeutic Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Therapeutic Vaccines Sales (K Units) by Type (2018-2024)
Table 22. Latin America Therapeutic Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Therapeutic Vaccines Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Therapeutic Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Therapeutic Vaccines Sales by Company (2018-2024) & (K Units)
Table 26. Global Therapeutic Vaccines Sales Share by Company (2018-2024)
Table 27. Global Therapeutic Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Therapeutic Vaccines Revenue Share by Company (2018-2024)
Table 29. Global Market Therapeutic Vaccines Price by Company (2018-2024) & (USD/Unit)
Table 30. Global Therapeutic Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Therapeutic Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Vaccines as of 2022)
Table 33. Date of Key Manufacturers Enter into Therapeutic Vaccines Market
Table 34. Key Manufacturers Therapeutic Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Therapeutic Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Therapeutic Vaccines Sales by Region (2018-2024) & (K Units)
Table 38. Global Therapeutic Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Therapeutic Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Therapeutic Vaccines Sales Market Share in Value by Region (2018-2024)
Table 41. Global Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 42. Global Therapeutic Vaccines Sales by Region (2024-2034) & (K Units)
Table 43. Global Therapeutic Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Therapeutic Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Therapeutic Vaccines Sales Market Share in Value by Region (2024-2034)
Table 46. Global Therapeutic Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 47. Global Therapeutic Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Therapeutic Vaccines Sales by Application (2018-2024) & (K Units)
Table 49. Global Therapeutic Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Therapeutic Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Therapeutic Vaccines Sales Market Share in Value by Application (2018-2024)
Table 52. Global Therapeutic Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 53. Global Therapeutic Vaccines Sales by Application (2024-2034) & (K Units)
Table 54. Global Therapeutic Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Therapeutic Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Therapeutic Vaccines Sales Market Share in Value by Application (2024-2034)
Table 57. Global Therapeutic Vaccines Price by Application (2024-2034) & (USD/Unit)
Table 58. North America Therapeutic Vaccines Sales by Application (2018-2024) (K Units)
Table 59. North America Therapeutic Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Therapeutic Vaccines Sales by Application (2018-2024) (K Units)
Table 61. Europe Therapeutic Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Therapeutic Vaccines Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Therapeutic Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Therapeutic Vaccines Sales by Application (2018-2024) (K Units)
Table 65. Latin America Therapeutic Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Therapeutic Vaccines Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Therapeutic Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Therapeutic Vaccines Sales by Country (2018-2024) & (K Units)
Table 69. North America Therapeutic Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Therapeutic Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Therapeutic Vaccines Sales Market Share in Value by Country (2018-2024)
Table 72. North America Therapeutic Vaccines Sales by Country (2024-2034) & (K Units)
Table 73. North America Therapeutic Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Therapeutic Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Therapeutic Vaccines Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Therapeutic Vaccines Sales by Country (2018-2024) & (K Units)
Table 77. Europe Therapeutic Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Therapeutic Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Therapeutic Vaccines Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Therapeutic Vaccines Sales by Country (2024-2034) & (K Units)
Table 81. Europe Therapeutic Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Therapeutic Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Therapeutic Vaccines Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Therapeutic Vaccines Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Therapeutic Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Therapeutic Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Therapeutic Vaccines Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Therapeutic Vaccines Sales by Region (2024-2034) & (K Units)
Table 89. Asia-Pacific Therapeutic Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Therapeutic Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Therapeutic Vaccines Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Therapeutic Vaccines Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Therapeutic Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Therapeutic Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Therapeutic Vaccines Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Therapeutic Vaccines Sales by Country (2024-2034) & (K Units)
Table 97. Latin America Therapeutic Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Therapeutic Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Therapeutic Vaccines Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Therapeutic Vaccines Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Therapeutic Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Therapeutic Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Therapeutic Vaccines Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Therapeutic Vaccines Sales by Country (2024-2034) & (K Units)
Table 105. Middle East and Africa Therapeutic Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Therapeutic Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Therapeutic Vaccines Sales Market Share in Value by Country (2024-2034)
Table 108. Northeast Biotherapeutics Company Information
Table 109. Northeast Biotherapeutics Introduction and Business Overview
Table 110. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 111. Northeast Biotherapeutics Therapeutic Vaccines Product
Table 112. Northeast Biotherapeutics Recent Development
Table 113. Agenus Company Information
Table 114. Agenus Introduction and Business Overview
Table 115. Agenus Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Agenus Therapeutic Vaccines Product
Table 117. Agenus Recent Development
Table 118. Vaccinogen Inc Company Information
Table 119. Vaccinogen Inc Introduction and Business Overview
Table 120. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Vaccinogen Inc Therapeutic Vaccines Product
Table 122. Vaccinogen Inc Recent Development
Table 123. CIMAB S.A Company Information
Table 124. CIMAB S.A Introduction and Business Overview
Table 125. CIMAB S.A Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. CIMAB S.A Therapeutic Vaccines Product
Table 127. CIMAB S.A Recent Development
Table 128. Dendreon Company Information
Table 129. Dendreon Introduction and Business Overview
Table 130. Dendreon Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Dendreon Therapeutic Vaccines Product
Table 132. Dendreon Recent Development
Table 133. Corixa Company Information
Table 134. Corixa Introduction and Business Overview
Table 135. Corixa Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Corixa Therapeutic Vaccines Product
Table 137. Corixa Recent Development
Table 138. AVAX Technologies Company Information
Table 139. AVAX Technologies Introduction and Business Overview
Table 140. AVAX Technologies Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. AVAX Technologies Therapeutic Vaccines Product
Table 142. AVAX Technologies Recent Development
Table 143. Key Raw Materials Lists
Table 144. Raw Materials Key Suppliers Lists
Table 145. Therapeutic Vaccines Market Trends
Table 146. Therapeutic Vaccines Market Drivers
Table 147. Therapeutic Vaccines Market Challenges
Table 148. Therapeutic Vaccines Market Restraints
Table 149. Therapeutic Vaccines Distributors List
Table 150. Therapeutic Vaccines Downstream Customers
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Vaccines Product Picture
Figure 2. Global Therapeutic Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Therapeutic Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Therapeutic Vaccines Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Peptide Therapeutic Vaccine
Figure 6. Global Peptide Therapeutic Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Cell Therapeutic Vaccine
Figure 8. Global Cell Therapeutic Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Nucleic Acid Therapeutic Vaccine
Figure 10. Global Nucleic Acid Therapeutic Vaccine Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Global Therapeutic Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Therapeutic Vaccines Sales Market Share by Type in 2022 & 2034
Figure 13. North America Therapeutic Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. North America Therapeutic Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Europe Therapeutic Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Europe Therapeutic Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Therapeutic Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Therapeutic Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Latin America Therapeutic Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Therapeutic Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Therapeutic Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Therapeutic Vaccines Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Therapeutic Vaccines Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Therapeutic Vaccines Revenue in 2022
Figure 25. Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Oncotherapy
Figure 27. Global Oncotherapy Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Product Picture of Hepatitis B
Figure 29. Global Hepatitis B Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Tuberculosis
Figure 31. Global Tuberculosis Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Herpes Simplex Virus
Figure 33. Global Herpes Simplex Virus Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Therapeutic Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Therapeutic Vaccines Sales Market Share by Application in 2022 & 2034
Figure 38. North America Therapeutic Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. North America Therapeutic Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Europe Therapeutic Vaccines Sales Market Share in Volume by Application in 2022
Figure 41. Europe Therapeutic Vaccines Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Therapeutic Vaccines Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Therapeutic Vaccines Sales Market Share in Value by Application in 2022
Figure 44. Latin America Therapeutic Vaccines Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Therapeutic Vaccines Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Therapeutic Vaccines Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Therapeutic Vaccines Manufacturing Cost Structure
Figure 49. Therapeutic Vaccines Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed